MedTrace Logo

To Vape or Not to Vape

NCT05240027 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 363

Last updated 2026-03-23

No results posted yet for this study

Summary

The overall goal of this study is to increase knowledge of vaping and its associated risks. This study will find the patterns of vaping, and how it all started among adolescents. Investigators want to know if students are aware of the serious and long term effects of vaping. This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population. Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure. Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products. Effectiveness of this program will be measured by pre and post-tests. Investigators believe this program will make at least 50 percent of the participants more aware of the dangers and consequences of vaping, potentially lowering the rates of those participating in this habit while also preventing others from starting.

Conditions

  • Vaping

Interventions

BEHAVIORAL

Vape use survey

pre \& post test surveys

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Maiya Bangurah, MBA · Methodist Health System Clinical Research Institute

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2021-02-26
Completion
2021-02-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05240027 on ClinicalTrials.gov